PEG vs RNAC · P/E 18, rev $10.29B vs P/E 2.1, rev $38.9M
Public Service Enterprise Group Inc (PEG) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the PEG and RNAC stock pages for the full models.
Not investment advice.